Plain-English translation of NCT05517434 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing two different cell-based treatments injected directly into the knee to see if they can reduce arthritis pain and improve how well your knee works. One treatment uses cells from your own bone marrow, and the other uses cells from your own fat tissue combined with platelets from your blood. Both are being compared to a placebo injection to find out which approach works best.
Knee arthritis affects millions of people and can be difficult to treat with current options. Researchers believe that using your own cells—which have natural healing properties—might help reduce pain and slow down joint damage better than existing treatments.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the cell-based treatment or a placebo injection into your knee under ultrasound guidance. Before the injection, you may undergo a bone marrow aspiration, fat tissue collection, or blood draw depending on which treatment group you are in. You will then be monitored with follow-up visits at 3, 6, and 12 months after your injection to track your pain levels, function, and any side effects, including X-rays to check your joint health.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Canada